<DOC>
	<DOCNO>NCT02460159</DOCNO>
	<brief_summary>This study ass safety tolerability Ezetimibe ( EZ ) 10 mg/Atorvastatin ( Atora ) 10 mg EZ 10mg/Atora 20 mg fixed-dose combination ( FDC ) Japanese participant hypercholesterolemia uncontrolled monotherapy Ezetimibe 10 mg Atorvastatin 20 mg . There formal hypothesis study .</brief_summary>
	<brief_title>A Clinical Trial Assess Long Term Safety Tolerability MK-0653C Japanese Participants With Hypercholesterolemia ( MK-0653C-384 )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Inclusion Criteria Japanese Outpatient hypercholesterolemia Has familial hypercholesterolemia ( FH ) diagnose per genetic test meet two criterion base Japan Atherosclerosis Society Guideline 2012 ( JAS2012 ) : Hyper lowdensity lipoprotein ( LDL ) cholesterolemia ( untreated LDLC level â‰¥180mg/dL ) ; tendon xanthoma ( tendon xanthoma back hand , elbow , knee , etc . achilles tendon hypertrophy ) xanthoma tuberosum ; family history FH premature coronary arterial disease ( within participant 's second degree relative ) Females must nonreproductive potential agree remain abstinent use ( partner use ) two acceptable method birth control date sign informed consent 14 day last dose study drug Agree maintain stable diet consistent JAS 2012 prevention atherosclerotic cardiovascular disease duration study Exclusion Criteria Uncontrolled hypertension Type 1 uncontrolled type 2 diabetes mellitus ( treat untreated ) Homozygous familial hypercholesterolemia undergone LDL apheresis Had gastrointestinal tract bypass , significant intestinal malabsorption History cancer within past 5 year except successfully treat dermatological basal cell squamous cell carcinoma situ cervical cancer Human immunodeficiency virus ( HIV ) positive History drug/ alcohol abuse within past 5 year psychiatric illness adequately control stable pharmacotherapy Consumes 25 g alcohol per day Consumes 1L grapefruit juice per day Currently follow excessive weight reduction diet Engaging vigorous exercise regimen ( e.g . ; marathon training , body build train etc . ) intend start training study Hypersensitivity intolerance ezetimibe atorvastatin History myopathy rhabdomyolysis ezetimibe statin Pregnant lactating Taking investigational drug and/or take investigational drug within 30 day</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>